User Name Password

back to homepage

Tirex Resources (TXX.V) - continuing the first modern exploration programme in Albania

Full Report by Objective Capital , Aug 08, 2008 (login for full report)
Click for previous reports on this company
Questions? Contact our analyst

Key Points:

  • Drilling at Koshaj yields encouraging high-grade assays
    Tirex selected Koshaj as its first target and the company recently wrapped up its nine-hole, first phase of drilling. Assays revealed substantial intersections of mineralisation containing higher grades of zinc, as expected, accompanied by a significant copper content. These results support the company’s geological model for Mirdita.

  • Gold at Koshaj provided a pleasant surprise
    Unexpectedly, Tirex’s assays from the Koshaj programme contained noteworthy values of gold and silver across the mineralised zone. The company now believes Mirdita has the potential to yield worthwhile amounts of precious metals beyond Koshaj. This expands the potential of the project significantly.

  • Gurthi Central could be the key to the Mirdita project
    Tirex recently commenced drilling at Gurthi Central, which contains two known deposits. Copper was the primary target, but the company also expects to find zinc-rich zones, and possibly exploitable quantities of gold and silver. The two deposits at Gurthi Central could offer the substantial size potential and higher grades to meet its goal of discovering and developing a large, Norandastyle volcanogenic massive sulphide deposit.

  • A high degree of risk accompanies the considerable exploration potential
    Tirex is the first explorer to employ modern techniques at Mirdita and all of its deposits and targets remain at the earlier stages of exploration. The company has yet to define an NI 43-101-compliant mineral resource at any of its targets. Given its goal of discovering multiple large tonnage high-grade deposits at Mirdita, the company’s exploration risk remains considerable. The possibility of finding lesser but nevertheless economic deposits on Mirdita partially mitigates the risk.

  • An increased valuation based on promising early results
    Our revised model places a base-case value of C$1.46 per share on Tirex. This is higher than our previous estimate of C$1.24 of November 2007. Our more optimistic assessment of C$2.52 per share, based on higher probabilities of exploration success, reflects the potential offered by further drilling on the key targets at Mirdita. Continued development offers potential for significant further increases

Free registration required for full report

SIGN UP NOW FOR OBJECTIVE'S STOCK RESEARCH - IT'S FREE!

Objective, Independent, Experienced.
Research you can trust!

Yes! Subscribe me for the latest stock research from Objective.
Email address
My Password
My information:
First Name
Family Name
Title:
Job title:
Job function:
Industry:
I am a:
 
To receive occasional printed reports complete your mailing address:
 
Company Name (if any)
Address
 
 
City
Postcode/Zip
Country

Please Read Objective's Terms of Use.


Balkan Resources (Private) - exploring the Perlati copper deposit in Albania
Oct 09, 2009 | Previous Reports

Scancell Holdings (SCLP.PLUS) - differentiated technology and a focused plan offer ingredients for success
Sep 08, 2009 | Previous Reports

Sofame Technologies (SDW.V) - ambitious, but high risk growth strategy
Aug 24, 2009 | Previous Reports

Soho Resources (SOH.V) - substantial upgrade to total resource
Aug 19, 2009 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

Colt Resources (COLT.CNQ) - Armamar Meda concession showing good potential
Mar 13, 2009 | Previous Reports

NioGold Mining Corp (NOX.V) - valuation robust despite recession and sector meltdown
Mar 10, 2009 | Previous Reports

Bridge BioResearch (private) - with some glimmer of efficacy, and safety already in evidence, clinical validation could offer lucrative returns
Dec 03, 2008 | Previous Reports

e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons
Nov 18, 2008 | Previous Reports

Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy
Nov 07, 2008 | Previous Reports

LiDCO (LID.L) - half year results show early signs of being on track
Oct 30, 2008 | Previous Reports

OCCASIONAL PAPERS

Albania - revisting old frontiers
October, 2008

The rise of independent research (IR Magazine)
March, 2006

Presentation to 2005 AIM Conference
Sept 26, 2005

The Role of Sponsored Research
June 22, 2005

Objective's Corporate Brochure
July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839

About Us | Contact Us
Latest Analysis | Register Free | Archives
 
Copyright 2004 Objective Capital. All rights reserved.
Terms of Use | Privacy Policy | Disclaimer